Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma
Stopped Some of the raw materials for the investigational drug are difficult to obtain and expensive.
Conditions
- Relapsed or Refractory Synovial Sarcoma
Interventions
- DRUG: OTSA101-DTPA-111In
- DRUG: OTSA101-DTPA-90Y
Sponsor
OncoTherapy Science, Inc.